Singular Health Group Ltd. announced the appointment of Kelyniam Global Inc. as the company's US-based agent, a key appointment and important pre-requisite to satisfy the final regulatory requirement, prior to Singular Health making sales in the US. Singular Health is also announced that CG1 Solutions has joined the recently formed 3Dicom Partner Program. CG1 Solutions will shortly commence promoting the diagnostic 3Dicom MD software for sale into US hospitals.

Kelyniam Global Inc. has been selected as the Company's US-based agent due to their current management's recent exceptional track record, highly skilled and flexible team, and strong reputation in the US patient specific implant market. The appointment of a US-based Agent is required by the FDA for all foreign entities, to act as the in-country point of contact and liaison on regulatory filings, product updates and other requirements, prior to making sales in the US market. Receptive to new technologies and with a well- established customer base of surgeons and well- incentivised sales force, Kelyniam is also very well positioned to both provide continual feedback on the 3Dicom Surgical software and AI cranial implant tool (under development), 3Dicom MD software (now diagnostically certified), and 3Dicom Patient with the soon-to-be-released Mobile App.

CG1 Solutions has recently joined Singular Health's newly established B2B "3Dicom Partner Program" and will be marketing both the non-diagnostic and diagnostic 3Dicom software offerings to their existing customer base, and conducting joint marketing activities with Singular Health at upcoming tradeshows and conferences. Singular Health's 3Dicom Partner Program, run by Dr. Martina Mariano, will see a focus on engaging with medical device manufacturers and digital health and medical technology companies to promote, market, and integrate Singular Health's 3Dicom software on a global scale, complementing and leveraging the direct-to-consumer channel. CG1 Solutions was identified as a founding member of Singular Health's 3Dicom Partner Program based on their shared vision of improving patient-specific outcomes through technologies, along with their existing presence in the US healthcare market providing services to large hospitals and clinics.

CG1 Solutions and Singular are currently pursuing opportunities to provide patient education solutions with 3Dicom in US hospitals and clinics. Under the 3Dicom Partner Program, Sales Partners are not currently bound to minimum sales volumes and each party incur their own costs.